ALLY vs BRK-B
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Ally Financial exhibits a stable health profile with a Piotroski F-Score of 4/9 and is significantly undervalued relative to its Graham Number ($47.52) and Intrinsic Value ($69.33). The company shows explosive earnings growth (265.4% YoY) and a highly attractive Forward P/E of 6.67 and PEG of 0.47. While low ROE (5.8%) and a bearish technical trend (0/100) present short-term headwinds, the fundamental valuation gap provides a substantial margin of safety. The stock is currently trading below book value (P/B 0.99), suggesting a strong entry point for value-oriented investors.
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Compare Another Pair
Related Comparisons
ALLY vs BRK-B: Head-to-Head Comparison
This page compares Ally Financial Inc. (ALLY) and Berkshire Hathaway Inc. (BRK-B) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.